Molecular Biomarker Profiling in Precision Oncology

Brought to you by ThermoFisher Scientific


While the content of this website is designed for healthcare professionals, this section provides basic information about molecular profiling of cancer and next-generation sequencing for oncology patients and their families and firends.

If you are interested in better understanding how Oncomine Solutions might be appropriate for you and your treatment, please ask your treating physician about precision oncology testing by next-generation sequencing.  



Celiac & GRD

Cancer biomarkers and precision oncology

No two cancers are exactly alike.  Small genetic changes within cancer cells, called biomarkers, can have a big impact on the effectiveness of certain cancer treatments.  For many cancers, scientists have identified biomarkers and are developing medications specifically designed to target them.  This new treatment strategy is called precision oncology.  It's precise because patients receive a therapy that matches their specific cancer type and biomarker expression.




Biopsy and molecular profiling  

In order to identify the biomarkers of your cancer and determine if there is a potential match with a "targeted therapy", your physician must take a sample of the cancer (either tissue or liquid biopsy) and send it to the lab.  The lab will perform a genetic test on the sample called next-generation sequencing (NGS) or molecular profiling.  



Celiac & GRD

Next-Generation Sequencing  

Next-generation sequencing (NGS) is an advanced genetic testing technique, which is performed on your cancer sample to identify all the biomarkers at once.  Results can be delivered in as little as 2-3 days.